BIODELIVERY SCIENCES INTERNATIONAL INC: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021): $166.7M
Net Income/Loss (FY2021): $84.9M
Total Assets (FY2021): $324.6M
Total Equity (FY2021): $187.8M
Cash Flows from Operating Activities (FY2021): $41.0M

Source: BIODELIVERY SCIENCES INTERNATIONAL INC 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

BIODELIVERY SCIENCES INTERNATIONAL INC: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021): $166.7M
Net Income/Loss (FY2021): $84.9M
Total Assets (FY2021): $324.6M
Total Equity (FY2021): $187.8M
Cash Flows from Operating Activities (FY2021): $41.0M

Source: BIODELIVERY SCIENCES INTERNATIONAL INC 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.